RECRUITINGOBSERVATIONAL

DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

How Does First Line Treatment With DSLT Perform in Treatment-naïve Patients With Newly Diagnosed Primary Open Angle Glaucoma

About This Trial

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

Who May Be Eligible (Plain English)

Who May Qualify: - Primary open angle glaucoma - Patients age 30 or greater with an IOP of 18-26 mmHg - Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines) - DSLT procedure Who Should NOT Join This Trial: - History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery - Angle closure patients - Ocular Hypertension - Baseline VF MD of worse than -12dB - Uncontrolled systemic microvascular disease (eg. HTN, DM) - Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium) Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Primary open angle glaucoma * Patients age 30 or greater with an IOP of 18-26 mmHg * Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines) * DSLT procedure Exclusion Criteria: * History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery * Angle closure patients * Ocular Hypertension * Baseline VF MD of worse than -12dB * Uncontrolled systemic microvascular disease (eg. HTN, DM) * Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)

Treatments Being Tested

DEVICE

DSLT enables newly diagnosed patients to remain well controlled and off medications

Locations (1)

Barnet Dulaney Perkins Eye Centers

Mesa, Arizona, United States